Litramine in Weight Maintenance
- Conditions
- OverweightWeight MaintenanceObese
- Interventions
- Dietary Supplement: LitramineDietary Supplement: Placebo
- Registration Number
- NCT01505387
- Lead Sponsor
- InQpharm Group
- Brief Summary
The effect of Litramine on weight loss has previously been studied during a 12-week intervention period with promising results. The present study looks into the effect of weight maintenance using Litramine following initial weight loss, for a longer period of 24 weeks.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
- Documented weight loss, achieved over the last 3 to 6 months either from participation in weight loss clinical trials or weight loss regimens, of at least 3% at the point of screening
- BMI 25-35 before initial weight loss
- Documented compliance (according to the investigator's judgement) to previous weight loss clinical trials/ regimens
- Known sensitivity to the ingredients of the device (citric acid, acacia or Fabaceae family)
- BMI < 18.5
- Presence of other factor(s) that, in the investigator's judgement, should preclude subject participation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Litramine Litramine Fibre complex of plant origin n tablet form 2 tablets 3 times daily (oral consumption, after meal) Placebo Placebo Identical to Litramine 2 tablets 3 times daily (oral consumption, after meal)
- Primary Outcome Measures
Name Time Method Mean Change in Body Weight From Baseline to End of 24 Weeks 24 weeks Change in body weight at the end of 24 weeks measured in kg using a calibrated scale. (positive values signify weight gain, while negative values signify weight reduction
- Secondary Outcome Measures
Name Time Method Blood Pressure 24 weeks Measured in mm Hg
Full Blood Count 24 weeks Erythrocytes, leukocytes, thrombocytes, haematocrit, haemoglobin, Mean corpuscular volume (MCV), Mean corpuscular haemaglobin (MCH)
Waist and Hip Circumference (cm) 24 weeks Changes from baseline to end of study
Body Mass Index (kg/m^2) 24 weeks Changes from baseline to end of study
Trial Locations
- Locations (1)
Barbara Grube
🇩🇪Berlin, Germany